Gestodene Implant

Product Overview

Alternative Name: Single Rod GES Implant

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Subdermal

Duration Type: Long-acting

Description: Subcutaneous single rod implant, made of silastic, containing gestodene.

Updated date: May 30, 2018

Vertical Tabs

Product Details

Active Pharmaceutical Ingredient (API): gestodene

Inactive material: Silicon rubber

Potential Multi-Purpose Technology (MPT): No

Duration: 3 years

Dose: 36 mg

Partner: Shanghai Institute of Planned Parenthood Research (SIPPR), Shanghai Dahua Pharmaceuticals, Ltd.

Status

Project Phase: Late Development

Project Stage: Phase III

Began discovery in: 2000

Status Details:
Product being developed mainly for Chinese market and ongoing trials may not meet standards of more stringent regulatory authorities or WHO pre-qualification.

Programmatic Considerations

Considerations:
Reported efficacy of >99.5% in ongoing Phase II trials, shelf life of 3 years.

Single rod placed in a capsule-like device with a thicker tubal wall may make insertion and removal easier.

Not suitable for use during lactation.

Additional Information

Additional Information:
Chen HL, Chen JX. (2007) Research on the New One Rod Contraceptive Implant Containing Gestodene. Journal of Reproduction and Contraception. 18(2):86-88.

Download Product Report

Alternative Name: Single Rod GES Implant

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Subdermal

Duration Type: Long-acting

Description: Subcutaneous single rod implant, made of silastic, containing gestodene.

Updated date: May 30, 2018

Vertical Tabs

Active Pharmaceutical Ingredient (API): gestodene

Inactive material: Silicon rubber

Potential Multi-Purpose Technology (MPT): No

Duration: 3 years

Dose: 36 mg

Partner: Shanghai Institute of Planned Parenthood Research (SIPPR), Shanghai Dahua Pharmaceuticals, Ltd.

Project Phase: Late Development

Project Stage: Phase III

Began discovery in: 2000

Status Details: Product being developed mainly for Chinese market and ongoing trials may not meet standards of more stringent regulatory authorities or WHO pre-qualification.

Considerations: Reported efficacy of >99.5% in ongoing Phase II trials, shelf life of 3 years. Single rod placed in a capsule-like device with a thicker tubal wall may make insertion and removal easier. Not suitable for use during lactation.

Additional Information: Chen HL, Chen JX. (2007) Research on the New One Rod Contraceptive Implant Containing Gestodene. Journal of Reproduction and Contraception. 18(2):86-88.

Status Details:
Product being developed mainly for Chinese market and ongoing trials may not meet standards of more stringent regulatory authorities or WHO pre-qualification.

Considerations:
Reported efficacy of >99.5% in ongoing Phase II trials, shelf life of 3 years.

Single rod placed in a capsule-like device with a thicker tubal wall may make insertion and removal easier.

Not suitable for use during lactation.

Additional Information:
Chen HL, Chen JX. (2007) Research on the New One Rod Contraceptive Implant Containing Gestodene. Journal of Reproduction and Contraception. 18(2):86-88.